Biotechnology Medical Technology Prevention 
Bill Of Health
SEPTEMBER 13, 2023
These five students are a fantastic cohort of health law policy, biotechnology, and bioethics scholars who join us from Harvard Law School. At the law school, Adithi is interested in examining how emerging biotechnologies in regenerative medicine intersect with patient privacy and other ownership rights.
Bill Of Health
OCTOBER 27, 2023
The HIPAA Problem The privatization of next-generation medical technologies, especially in regenerative and precision medicine, further muddies the data-protection waters. The innovation-security tradeoff is a familiar trope in biotechnology, but the main character of the direct-to-consumer tissue-based service story is less so.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bill Of Health
NOVEMBER 10, 2022
The emergence of digital platforms and related technologies are transforming healthcare and creating new opportunities and challenges for all stakeholders in the medical space.
Bill Of Health
SEPTEMBER 13, 2023
While demonstrating the artificial distinction between those concepts, the comparison highlighted Israeli regulation as presenting a clear and wide spectrum of clinical diagnostic criteria as well as a relatively generous funding scheme for medically-indicated egg freezing. The Israeli situation is a unique example of this overall trend.
Bill Of Health
MAY 20, 2024
Additionally, it is yet to be determined how the new AI Act will synchronize with other legislative proposals like the European Health Data Space (EHDS) , and existing EU regulations such as the General Data Protection Regulation (GDPR) and the Medical Device Regulation (MDR).
Bill Of Health
AUGUST 12, 2021
Activists anticipated the rise of vaccine, therapeutic, and testing nationalism — with rich countries securing preferential access to COVID-19 medical technologies and preventing export to other countries even before they had been approved — and the press soon followed.
HIT Consultant
OCTOBER 1, 2024
Ivor Campbell, CEO of Snedden Campbell The global landscape for medical technology, biotechnology, and life sciences is on the cusp of seismic change. About Ivor Campbell Ivor Campbell is Chief Executive of Angus-based Snedden Campbell, a specialist recruitment consultant for the medical technology industry.
Expert insights. Personalized for you.
59 
Let's personalize your content